Fingerpaint Acquires London-Based Data and Analytics Firm Engage, Solidifying Its Global Footprint
Fingerpaint, biopharma’s global commercialization partner for analytics-enabled integrated solutions, announced it acquired Engage, a London-based, award-winning, data and analytics–enabled healthcare marketing firm.
Engage will expand Fingerpaint’s European footprint and complement the company’s current data and analytics expertise.
“Strengthening our global infrastructure is reflective of the diversified biopharma industry we serve worldwide,” said Ed Mitzen, founder of Fingerpaint. “Our combined global omnichannel marketing solutions guided by—and rooted in—data will further Fingerpaint’s position as a transformative digital partner to biopharma’s commercialization needs.”
Dave Chandler, Ed Mitzen, and Mary McGregor (L to R)
Mary McGregor and Dave Chandler, both founders and managing partners of Engage, will continue to lead day-to-day operations.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
